Patient Presentation, Skin Biopsy Utilization and Cutaneous Malignant Melanoma Incidence and Mortality in Northern Italy: Trends and Correlations

Background: The global increase in incidence of cutaneous malignant melanoma (CMM) occurring in the past decades has been partly attributed to increased diagnostic scrutiny of early lesions, with a potential phenomenon of overdiagnosis. The reported positive linear relation between skin biopsy rate and incidence of early CMM is compatible with this hypothesis.

Objectives: We explored the ecological association between the trends in annual dermatologic office visit rates, skin biopsy rates, incidence rates of in situ and invasive CMM by tumour thickness category, and CMM mortality rates in the Emilia-Romagna Region (northern Italy).

Methods: Four cancer registries covering a population of 2,696,000 provided CMM incidence data for the years 2003-2017. Dermatologic office visit rates and skin biopsy rates were calculated using the Regional outpatient care database. All rates were age-standardized. Trends were described with the estimated average annual per cent change (EAAPC). Correlations were tested with the Spearman correlation coefficient.

Results: Incidence increased significantly. The increase was steeper for in situ CMM (EAAPC: men, 10.2; women, 6.9) followed by CMM <0.8 mm thick (9.1; 5.2), but the rates grew significantly for most subgroups of CMMs ≥0.8 mm thick. Mortality decreased significantly among women (-2.3) and non-significantly among men. For dermatologic office visit rate and skin biopsy rate the EAAPC were, respectively, 1.7 and 1.8 for men and 1.2 and 0.9 for women. Annual dermatologic office visit rate correlated with skin biopsy rate in both sexes. However, the proportion of skin biopsies out of dermatologic office visits was constant across the years (range: men, 0.182-0.216; women, 0.157-0.191).

Conclusions: In Italy, the increasing CMM incidence trend is, at least in part, genuine. Overdiagnosis-if any-is due to an increased patient presentation at dermatologic offices and not to a lower dermatologic threshold to perform biopsy.

Citing Articles

Cost-Benefit Analysis of in vivo Reflectance Confocal Microscopy for Melanoma Diagnosis in a Real-World Clinical Setting.

Bruno G, Di Matteo S, Longo C, Stanganelli I, Farnetani F, Borsari S Risk Manag Healthc Policy. 2025; 18():163-172.

PMID: 39839194 PMC: 11745940. DOI: 10.2147/RMHP.S487814.

Evaluation of a training course for general practitioners within the melanoma multimedia education programme of the Italian Melanoma Intergroup: a study protocol.

Stanganelli I, Magi S, Bucchi L, Crocetti E, Mancini S, Vattiato R Dermatol Reports. 2024; 16(3):9919.

PMID: 39484362 PMC: 11526653. DOI: 10.4081/dr.2024.9919.

Preliminary analysis of the melanoma multimedia educational program for general practitioners on behalf of the Italian Melanoma Intergroup.

Zamagni F, Falcini F, Magi S, Bucchi L, Mancini S, Vattiato R Dermatol Reports. 2024; 16(3):9920.

PMID: 39290553 PMC: 11404542. DOI: 10.4081/dr.2024.9920.

Evaluation of an Italian Population-Based Programme for Risk Assessment and Genetic Counselling and Testing for BRCA1/2-Related Hereditary Breast and Ovarian Cancer after 10 Years of Operation: An Observational Study Protocol.

Ferretti S, Sassoli de Bianchi P, Canuti D, Campari C, Cortesi L, Arcangeli V Methods Protoc. 2024; 7(4).

PMID: 39195440 PMC: 11357531. DOI: 10.3390/mps7040063.

Cutaneous melanoma in older patients.

Buja A, Rugge M, Trevisiol C, Zanovello A, Brazzale A, Zorzi M BMC Geriatr. 2024; 24(1):232.

PMID: 38448833 PMC: 10916215. DOI: 10.1186/s12877-024-04806-8.

References

Salerni G, Alonso C, Fernandez-Bussy R . A series of small-diameter melanomas on the legs: dermoscopic clues for early recognition. Dermatol Pract Concept. 2015; 5(4):31-6. PMC: 4667599. DOI: 10.5826/dpc.0504a08. View

Watts C . The challenge of skin surveillance: observe or biopsy?. Br J Dermatol. 2017; 176(4):851-852. DOI: 10.1111/bjd.15450. View

Garbe C, Keim U, Gandini S, Amaral T, Katalinic A, Hollezcek B . Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943-2036. Eur J Cancer. 2021; 152:18-25. DOI: 10.1016/j.ejca.2021.04.029. View

Mackie R, Bray C, Hole D, Morris A, Nicolson M, Evans A . Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet. 2002; 360(9333):587-91. DOI: 10.1016/S0140-6736(02)09779-9. View

Berwick M, Reiner A, Paine S, Armstrong B, Kricker A, Goumas C . Sun exposure and melanoma survival: a GEM study. Cancer Epidemiol Biomarkers Prev. 2014; 23(10):2145-52. PMC: 4184941. DOI: 10.1158/1055-9965.EPI-14-0431. View

Bucchi L, Mancini S, Zamagni F, Crocetti E, Dal Maso L, Ferretti S . Patient presentation, skin biopsy utilization and cutaneous malignant melanoma incidence and mortality in northern Italy: Trends and correlations. J Eur Acad Dermatol Venereol. 2022; 37(2):293-302. PMC: 10092783. DOI: 10.1111/jdv.18635. View

Shaikh W, Dusza S, Weinstock M, Oliveria S, Geller A, Halpern A . Melanoma Thickness and Survival Trends in the United States, 1989 to 2009. J Natl Cancer Inst. 2015; 108(1). PMC: 4857148. DOI: 10.1093/jnci/djv294. View

Erdmann F, Lortet-Tieulent J, Schuz J, Zeeb H, Greinert R, Breitbart E . International trends in the incidence of malignant melanoma 1953-2008--are recent generations at higher or lower risk?. Int J Cancer. 2012; 132(2):385-400. DOI: 10.1002/ijc.27616. View

de Vries E, Bray F, Coebergh J, Parkin D . Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer. 2003; 107(1):119-26. DOI: 10.1002/ijc.11360. View

10.

Weinstock M, Lott J, Wang Q, Titus L, Onega T, Nelson H . Skin biopsy utilization and melanoma incidence among Medicare beneficiaries. Br J Dermatol. 2016; 176(4):949-954. PMC: 5357200. DOI: 10.1111/bjd.15077. View

11.

Hollestein L, van den Akker S, Nijsten T, Karim-Kos H, Coebergh J, de Vries E . Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989. Ann Oncol. 2011; 23(2):524-30. DOI: 10.1093/annonc/mdr128. View

12.

Welch H, Mazer B, Adamson A . The Rapid Rise in Cutaneous Melanoma Diagnoses. N Engl J Med. 2021; 384(1):72-79. DOI: 10.1056/NEJMsb2019760. View

13.

Gandini S, Montella M, Ayala F, Benedetto L, Rossi C, Vecchiato A . Sun exposure and melanoma prognostic factors. Oncol Lett. 2016; 11(4):2706-2714. PMC: 4812599. DOI: 10.3892/ol.2016.4292. View

14.

Chiarugi A, Nardini P, Borgognoni L, Brandani P, Gerlini G, Rubegni P . Thick melanoma in Tuscany. G Ital Dermatol Venereol. 2017; 154(6):638-645. DOI: 10.23736/S0392-0488.17.05584-5. View

15.

Crocetti E, Carli P . Unexpected reduction of mortality rates from melanoma in males living in central Italy. Eur J Cancer. 2003; 39(6):818-21. DOI: 10.1016/s0959-8049(03)00056-x. View

16.

Montella A, Gavin A, Middleton R, Autier P, Boniol M . Cutaneous melanoma mortality starting to change: a study of trends in Northern Ireland. Eur J Cancer. 2009; 45(13):2360-6. DOI: 10.1016/j.ejca.2009.03.004. View

17.

van der Leest R, Zoutendijk J, Nijsten T, Mooi W, van der Rhee J, de Vries E . Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?. Eur J Cancer. 2015; 51(18):2833-41. DOI: 10.1016/j.ejca.2015.09.008. View

18.

Goldsmith S, Solomon A . A series of melanomas smaller than 4 mm and implications for the ABCDE rule. J Eur Acad Dermatol Venereol. 2007; 21(7):929-34. DOI: 10.1111/j.1468-3083.2006.02115.x. View

19.

Bucchi L, Mancini S, Crocetti E, Dal Maso L, Baldacchini F, Vattiato R . Mid-term trends and recent birth-cohort-dependent changes in incidence rates of cutaneous malignant melanoma in Italy. Int J Cancer. 2021; 148(4):835-844. DOI: 10.1002/ijc.33259. View

20.

Stang A, Stang K, Stegmaier C, Hakulinen T, Jockel K . Skin melanoma in Saarland: incidence, survival and mortality 1970-1996. Eur J Cancer Prev. 2001; 10(5):407-15. DOI: 10.1097/00008469-200110000-00004. View